[go: up one dir, main page]

PL1626051T3 - Kryształy solwatu pochodnej kwasu chinolinokarboksylowego - Google Patents

Kryształy solwatu pochodnej kwasu chinolinokarboksylowego

Info

Publication number
PL1626051T3
PL1626051T3 PL04730102T PL04730102T PL1626051T3 PL 1626051 T3 PL1626051 T3 PL 1626051T3 PL 04730102 T PL04730102 T PL 04730102T PL 04730102 T PL04730102 T PL 04730102T PL 1626051 T3 PL1626051 T3 PL 1626051T3
Authority
PL
Poland
Prior art keywords
crystals
acid derivative
quinolinecarboxylic acid
solvate
derivative solvate
Prior art date
Application number
PL04730102T
Other languages
English (en)
Inventor
Jun Akai
Hiroshi Nishida
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Publication of PL1626051T3 publication Critical patent/PL1626051T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL04730102T 2003-04-30 2004-04-28 Kryształy solwatu pochodnej kwasu chinolinokarboksylowego PL1626051T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2003124643 2003-04-30
JP2004006057 2004-01-13
EP04730102A EP1626051B1 (en) 2003-04-30 2004-04-28 Crystals of quinolinecarboxylic acid derivative solvate
PCT/JP2004/006216 WO2004096815A1 (ja) 2003-04-30 2004-04-28 キノリンカルボン酸誘導体溶媒和物の結晶

Publications (1)

Publication Number Publication Date
PL1626051T3 true PL1626051T3 (pl) 2012-10-31

Family

ID=33422075

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04730102T PL1626051T3 (pl) 2003-04-30 2004-04-28 Kryształy solwatu pochodnej kwasu chinolinokarboksylowego

Country Status (13)

Country Link
US (1) US7612205B2 (pl)
EP (2) EP1626051B1 (pl)
JP (1) JP4655930B2 (pl)
KR (1) KR101088988B1 (pl)
AU (2) AU2004234287A1 (pl)
BR (1) BRPI0409930A (pl)
CA (1) CA2523854C (pl)
ES (1) ES2388921T3 (pl)
MX (1) MXPA05011525A (pl)
PL (1) PL1626051T3 (pl)
PT (1) PT1626051E (pl)
RU (1) RU2335503C2 (pl)
WO (1) WO2004096815A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN2012MN02925A (pl) * 2010-06-30 2015-05-22 Cipla Ltd
RU2484768C1 (ru) * 2012-02-07 2013-06-20 Государственное бюджетное образовательное учреждение высшего профессионального образования "Воронежская государственная медицинская академия им. Н.Н. Бурденко" Министерства здравоохранения и социального развития Российской Федерации Способ прогнозирования течения глаукомной оптической нейропатии
EP3773579A4 (en) 2018-03-26 2022-03-09 Clear Creek Bio, Inc. COMPOSITIONS AND METHODS FOR INHIBITING DIHYDROOROTATE DEHYDROGENASE
CA3175964A1 (en) * 2020-03-20 2021-09-23 Clear Creek Bio, Inc. Stable polymorphic compositions of brequinar sodium and methods of use and manufacture thereof
US12076315B2 (en) 2020-03-20 2024-09-03 Clear Creek Bio, Inc. Stable polymorphic compositions of brequinar sodium and methods of use and manufacture thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0751579B2 (ja) * 1987-11-07 1995-06-05 日本新薬株式会社 キノリンカルボン酸誘導体
SU1558915A1 (ru) * 1988-07-29 1990-04-23 Пермский фармацевтический институт 2-(5 @ -Нитрофурил)-2,3-дигидро-5Н-1,3,4-тиадиазоло[2,3-в]-хиназолинон-5, про вл ющий противомикробную активность

Also Published As

Publication number Publication date
RU2005137156A (ru) 2006-06-10
RU2335503C2 (ru) 2008-10-10
WO2004096815A1 (ja) 2004-11-11
MXPA05011525A (es) 2005-12-12
JP4655930B2 (ja) 2011-03-23
CA2523854C (en) 2012-10-16
EP1626051A1 (en) 2006-02-15
EP1626051B1 (en) 2012-06-13
BRPI0409930A (pt) 2006-04-25
PT1626051E (pt) 2012-08-01
JPWO2004096815A1 (ja) 2006-07-13
KR20060008930A (ko) 2006-01-27
US7612205B2 (en) 2009-11-03
EP1626051A4 (en) 2008-06-25
AU2010201309A1 (en) 2010-04-22
AU2004234287A1 (en) 2004-11-11
AU2010201309B2 (en) 2011-10-13
EP2354144A1 (en) 2011-08-10
ES2388921T3 (es) 2012-10-19
US20070149540A1 (en) 2007-06-28
CA2523854A1 (en) 2004-11-11
KR101088988B1 (ko) 2011-12-01

Similar Documents

Publication Publication Date Title
AP2006003619A0 (en) Novel quinoline derivatives
ZA200509319B (en) Quinoline derivatives as phosphodiesterase inhibitors
IL183185A0 (en) Process of making crystalline aripiprazole
AU2003230192A1 (en) Novel crystalline forms of aripiprazole
PL1666477T3 (pl) Pochodna kwasu 7-(4-podstawionego-3-cyklopropyloaminometylo-1- pirolidynylo)chinolonokarboksylowego
IL164645A0 (en) Polymorph of 4-Ä2-Ä1-(2-ethoxyethyl)-1H-benzidimazole-2-YLÜ-1-piperidinylÜethylÜ-??-dimethyl-benzenoacetic acid
AP2008004444A0 (en) New anti-malaria derivatives of 4-aminoquinoline
PL1620396T3 (pl) Sposób otrzymywania N-podstawionych 2-cyjanopirolidyn
IL174238A0 (en) Process for the preparation of n- amino substituted heterocyclic compounds
AU2003238671A1 (en) Novel crystalline forms of s-omeprazole magnesium
IL165115A0 (en) Novel crystalline forms of gatifloxacin
AU2003248657A1 (en) Polymorphic form xvi of fexofenadine hydrochloride
PL1626051T3 (pl) Kryształy solwatu pochodnej kwasu chinolinokarboksylowego
IL172629A0 (en) Process for the preparation of nonpeptide substituted spirobenzoazepine derivatives
IL175654A0 (en) Cycloalkyl derivatives of 3-hydroxy -4-pyridinones
EP1632476A4 (en) ACIDIC ACID SALT OF A CARBAZUCKERAMINE DERIVATIVE
IL166592A0 (en) Novel crystalline forms of gatifloxacin
SI1656358T1 (sl) Stabilen polimorf bifeprunox mezilata
AU2003225049A1 (en) Polymorph of ascomycin derivative
IL165690A0 (en) Novel crystalline forms of gatifloxacin
ZA200507475B (en) Derivatives of azithromycin
EP1486485A4 (en) NEW 5-HYDROXYCARBAMIMIDOYL-2-HYDROXYBENZENESULFONAMIDE DERIVATIVE CRYSTALS
TW567830U (en) Structure of cutter for endoscopes
AU2003231527A8 (en) Novel derivatives of carnosic acid
IL174063A0 (en) Crystalline form of gatifloxacin